PREVALENCE AND CHARACTERISTICS OF PATIENTS LOST TO FOLLOW-UP IN US CF FOUNDATION PATIENT REGISTRY

Elbert A.; Petren K.; Fink A.; Marshall B.

首页> 外文期刊>Pediatric Pulmonology >PREVALENCE AND CHARACTERISTICS OF PATIENTS LOST TO FOLLOW-UP IN US CF FOUNDATION PATIENT REGISTRY

【24h】

PREVALENCE AND CHARACTERISTICS OF PATIENTS LOST TO FOLLOW-UP IN US CF FOUNDATION PATIENT REGISTRY

机译：美国CF基金会患者注册中失访患者的流行情况和特征

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Pediatric Pulmonology 》 |2015年第41期| 共1页
作者
Elbert A.; Petren K.; Fink A.; Marshall B.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类儿科学 ;
关键词

相似文献

外文文献
中文文献
专利

1. PREVALENCE AND CHARACTERISTICS OF PATIENTS LOST TO FOLLOW-UP IN US CF FOUNDATION PATIENT REGISTRY [J] . Elbert A., Petren K., Fink A., Pediatric Pulmonology . 2015 ,第Suppla41期

机译：美国CF基金会患者注册中失访患者的流行情况和特征
2. Patient and site characteristics associated with pirfenidone and nintedanib use in the United States; an analysis of idiopathic pulmonary fibrosis patients enrolled in the Pulmonary Fibrosis Foundation Patient Registry [J] . Colin H. Holtze, Elizabeth A. Freiheit, Susan L. Limb, Respiratory Research . 2020 ,第1期

机译：与Pirfenidone和Nintedanib在美国的患者和网站特征;患有肺纤维化基患者登记处的特发性肺纤维化患者分析
3. USE OF AN ELECTRONIC MEDICAL RECORD TEMPLATE TO CAPTURE CLINICAL AND PATIENT REPORTED DATA FOR THE CF FOUNDATION PATIENT REGISTRY [J] . Gifford A. H., Snide J. A., Sabadosa K. Pediatric Pulmonology . 2019 ,第Suppla2期

机译：使用电子医疗记录模板捕获CF基础患者注册表的临床和患者报告的数据
4. Prevalence and Characteristics of Neuropathic Pain in 358 Patients with Leprosy [C] . Patrick R.N.A.G. Stump, Rosemari Baccarelli, Lucia H.S.C. Marciano, World Congress on Pain . 2003

机译：358例麻风病患者神经性疼痛的患病率和特征
5. Prevalence, characteristics and health consequences of abnormal body composition phenotypes in patients with malignant disease. [D] . Marques Maia do Prado, Carla. 2009

机译：恶性疾病患者身体组成异常表型的普遍性，特征和健康后果。
6. Patient and site characteristics associated with pirfenidone and nintedanib use in the United States; an analysis of idiopathic pulmonary fibrosis patients enrolled in the Pulmonary Fibrosis Foundation Patient Registry [O] . Colin H. Holtze, Elizabeth A. Freiheit, Susan L. Limb, 2020

机译：在美国使用吡非尼酮和nintedanib相关的患者和部位特征；肺纤维化基金会患者登记处登记的特发性肺纤维化患者的分析
7. MS1 VALIDATION OF MODELED 5-YEAR SURVIVAL OUTCOMES AMONG PATIENTS WITH CYSTIC FIBROSIS (CF) TREATED WITH THE CF TRANSMEMBRANE CONDUCTANCE REGULATOR MODULATOR (CFTRM) IVACAFTOR USING US CF FOUNDATION PATIENT REGISTRY (USCFFPR) DATA [O] . L. Mcgarry, A. Lopez, C. Chandler, 2020

机译：使用US CF基础患者登记处（USCFFPR）数据，用CF跨膜电导调节器调制器（CFTRM）Ivacaftor（CFTRM）数据（USCFFPR）数据治疗囊性纤维化患者模型5年生存结果的MS1验证

PREVALENCE AND CHARACTERISTICS OF PATIENTS LOST TO FOLLOW-UP IN US CF FOUNDATION PATIENT REGISTRY

著录项

相似文献

相关主题

期刊订阅